Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Integration of Nanostring Profiling and Functional Characterization of Oxidative and Replicative Stress Biomarkers Identifies Poor Prognosis MYC/BCL-2 Positive Diffuse Large B-Cell Lymphoma Subsets, Providing Opportunities for Precision Therapies

Enrico Derenzini, MD PhD, Alessandra Rossi, PhD, Claudio Agostinelli, MD, Maura Rossi, PhD, Federica Melle, PhD, Giovanna Motta, PhD, Marco Fabbri, PhD, Tommaso Radice, MD, Safaa Ramadan, PhD MD, Anna Vanazzi, MD, Valentina Tabanelli, MD, Stefano Fiori, MD, Annalisa Chiappella, MD, Alberto Agazzi, MD, Pier Luigi Zinzani, MD, Umberto Vitolo, Corrado Tarella, MD Prof, Stefano A. Pileri, MD PhD

Blood (2018) 132 (Supplement 1): 676.

https://doi.org/10.1182/blood-2018-99-118329

Published: 2018

Journal Articles

Genomic Instability and Activation Of The DNA Damage Response Pathway Is An Independent Predictor Of Poor Prognosis, Is Associated With MYC Expression and Is a Promising Target For Therapy In Diffuse Large B Cell Lymphoma

Enrico Derenzini, MD, Claudio Agostinelli, MD, Ilaria Iacobucci, PhD, Enrica Imbrogno, Beatrice Casadei, MD, Giovanni Martinelli, MD, Stefano A Pileri, MD, Pier Luigi Zinzani, MD

Blood (2013) 122 (21): 3015.

https://doi.org/10.1182/blood.V122.21.3015.3015

Published: 2013

Journal Articles

Gene Expression Analysis of Follicular Lymphoma Provides a Potential Rationale for Histological Grading Revision.

Pier Paolo Piccaluga, MD, PhD, Andrea Califano, PhD, Ulf Klein, PhD, Claudio Agostinelli, MD, Beartiz Bellosillo, MD, Eva Gimeno, MD, Sergi Serrano, MD, Francisco Solè, MD, Yonghui Zang, PhD, Brunangelo Falini, MD, Pier Luigi Zinzani, MD, Stefano A. Pileri, MD

Blood (2007) 110 (11): 186.

https://doi.org/10.1182/blood.V110.11.186.186

Published: 2007

Journal Articles

Marker Expression in Peripheral T-Cell Lymphoma Unspecified: Proposal of a Clinical-Pathologic Prognostic Score.

Pier Paolo Piccaluga, MD, PhD, Philip Went, MD, Claudio Agostinelli, MD, Andrea Gallamini, MD, Stefano Ascani, MD, Elena Sabattini, MD, Francesco Bacci, MD, Brunangelo Falini, MD, Teresio Motta, MD, Marco Paulli, MD, Tullio Artusi, MD, Pier Luigi Zinzani, MD, Michele Baccarani, MD, Stefano A. Pileri, MD, on Behalf of the Intergruppo Italiano Linfomi

Blood (2005) 106 (11): 2819.

https://doi.org/10.1182/blood.V106.11.2819.2819

Published: 2005

Journal Articles

Gene Expression Analysis of Peripheral T-Cell Lymphoma Not Otherwise Specified Reveals the Existance of Two Subgroups Related to Different Cellular Counterparts and Recurrent PDGFRA Deregulation.

Pier-Paolo Piccaluga, MD, PhD, Claudio Agostinelli, MD, Simona Zupo, MD, Andrea Califano, PhD, Philip Went, MD, Stefano Ascani, MD, Katia Basso, PhD, Fabio Facchetti, MD, Brunangelo Falini, MD, Manlio Ferrarini, MD, Andrea Gallamini, MD, Ulf Klein, PhD, Domenico Novero, MD, Marco Paulli, MD, Sante Tura, MD, Pier Luigi Zinzani, MD, Michele Baccarani, MD, Riccardo Dalla-Favera, MD, Stefano A. Pileri, MD

Blood (2005) 106 (11): 1217.

https://doi.org/10.1182/blood.V106.11.1217.1217

Published: 2005

NARROW

Integration of Nanostring Profiling and Functional Characterization of Oxidative and Replicative Stress Biomarkers Identifies Poor Prognosis MYC/BCL-2 Positive Diffuse Large B-Cell Lymphoma Subsets, Providing Opportunities for Precision Therapies

Genomic Instability and Activation Of The DNA Damage Response Pathway Is An Independent Predictor Of Poor Prognosis, Is Associated With MYC Expression and Is a Promising Target For Therapy In Diffuse Large B Cell Lymphoma

Gene Expression Analysis of Follicular Lymphoma Provides a Potential Rationale for Histological Grading Revision.

Marker Expression in Peripheral T-Cell Lymphoma Unspecified: Proposal of a Clinical-Pathologic Prognostic Score.

Gene Expression Analysis of Peripheral T-Cell Lymphoma Not Otherwise Specified Reveals the Existance of Two Subgroups Related to Different Cellular Counterparts and Recurrent PDGFRA Deregulation.

Email alerts

ASH Publications

American Society of Hematology

Integration of Nanostring Profiling and Functional Characterization of Oxidative and Replicative Stress Biomarkers Identifies Poor Prognosis MYC/BCL-2 Positive Diffuse Large B-Cell Lymphoma Subsets, Providing Opportunities for Precision Therapies

Genomic Instability and Activation Of The DNA Damage Response Pathway Is An Independent Predictor Of Poor Prognosis, Is Associated With MYC Expression and Is a Promising Target For Therapy In Diffuse Large B Cell Lymphoma

Gene Expression Analysis of Follicular Lymphoma Provides a Potential Rationale for Histological Grading Revision.

Marker Expression in Peripheral T-Cell Lymphoma Unspecified: Proposal of a Clinical-Pathologic Prognostic Score.

Gene Expression Analysis of Peripheral T-Cell Lymphoma Not Otherwise Specified Reveals the Existance of Two Subgroups Related to Different Cellular Counterparts and Recurrent PDGFRA Deregulation.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only